3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Breast
1
Conditions
Prostatic Neoplasms
2
Neoplasms
1
Financial Stress
1
Breast Neoplasms
1
Interventions
Docetaxel
277
Prednisone
237
enzalutamide
177
Leuprolide
172
Radiotherapy
164
Abiraterone Acetate
154
Magnetic Resonance Spectroscopy
147
bicalutamide
137
Goserelin
134
Androgen Antagonists
111
Radiosurgery
101
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
100
apalutamide
79
abiraterone
77
gallium 68 PSMA-11
74
Specimen Handling
67
darolutamide
58
Gonadotropin-Releasing Hormone
58
Radiation
56
Triptorelin Pamoate
53
cabazitaxel
50
Zoledronic Acid
49
pembrolizumab
48
Radiotherapy, Intensity-Modulated
47
Flutamide
47
Brachytherapy
47
luprolide acetate gel depot
46
Standard of Care
45
Carboplatin
44
Estramustine
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Neoplasms
×
Immunization, Secondary
×
Clear all
NCT04766190
2025-05-25
DISCO
Barbara Ann Karmanos Cancer Institute
Phase NA
Recruiting
260 enrolled
NCT00715104
2015-05-04
NeoACT
Dendreon
Phase 2
Completed
42 enrolled
18 charts